[Beta]- aminothiols and the regulation of hepatic oxalate production / Paul Wayne Baker.

The investigations centre on the use of [beta]-aminothiols (cysteine, cysteamine and penicillamine) to decrease endogenous oxalate production by forming adducts with glyoxylate, the immediate precursor of oxalate. They indicate that cysteine delivery drugs like OTC have the potential to aid in management of calcium oxalate stone disease, thereby reducing endogenous oxalate production and urinary oxalate excretion.

Author dc:creator

• Baker, Paul Wayne

Language dc:language.iso

en

Handle dc:identifier.uri

http://hdl.handle.net/2440/18547

OAI identifier oai:identifier

oai:digital.library.adelaide.edu.au:2440/18547